U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2021
470
Substance Class Protein
Created
by admin
on Sat Dec 16 16:08:06 GMT 2023
Edited
by admin
on Sat Dec 16 16:08:06 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Record UNII
N7Q9NLF11I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LY-3832479
Preferred Name English
ETESEVIMAB
USAN   INN  
Official Name English
ANTI-SARS-COV-2 ANTIBODY JS016
Common Name English
CB6
Code English
JS016
Code English
NP-005
Code English
LY COV016
Code English
LY3832479
Code English
IMMUNOGLOBULIN G1*03-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN, E2))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HOMO SAPIENS VH (IGHV3-66*01 (97%) (IGHD)-IGHJ4*01 (93%)) (8.7.13) (1-119)-
Common Name English
CB-6
Code English
Etesevimab [WHO-DD]
Common Name English
JS-016
Code English
etesevimab [INN]
Common Name English
ETESEVIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL JS016 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS016 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3832479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3832479 .KAPPA.-CHAIN, DIMER
Common Name English
NP005
Code English
LY-COV016
Code English
Code System Code Type Description
CAS
2423948-94-9
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
INN
11873
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
FDA UNII
N7Q9NLF11I
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
RXCUI
2477854
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
SMS_ID
300000026913
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
NCI_THESAURUS
C173977
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
DAILYMED
N7Q9NLF11I
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
USAN
JK-03
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
From To
4_136 4_196
4_23 4_88
3_136 3_196
3_23 3_88
2_369 2_427
2_263 2_323
2_222 4_216
2_146 2_202
2_22 2_95
1_369 1_427
1_263 1_323
1_231 2_231
1_228 2_228
1_222 3_216
1_146 1_202
1_22 1_95
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
SPIKE-1 PROTEIN SARS-COV-2
TARGET->LIGAND
Blocks attachment of the virus to human angiotensin-converting enzyme 2 (ACE2) receptors, preventing subsequent viral entry into human cells and viral replication.
SARS-COV2
TARGET ORGANISM->INHIBITOR
Related Record Type Details
ETESEVIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966